Michael Kaswan

Insider Reports History

Entity
Individual
Location
Kbl Healthcare Acquisition Corp II, 645 Madison Avenue, New York, New York
Signature
/s/ Matthew R. Schob, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Kaswan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Orchestra BioMed Holdings, Inc. Chief Financial Officer Common Stock, par value $0.0001 per share ("Common Stock") 163K $176K $1.08 Apr 12, 2023 Direct
Orchestra BioMed Holdings, Inc. Chief Financial Officer Nonstatutory Stock Option (Right to Buy) 193K Jan 26, 2023 Direct
Orchestra BioMed Holdings, Inc. Chief Financial Officer Right to Receive Earnout Shares 29K Apr 12, 2023 Direct

Insider Reports Filed by Michael Kaswan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OBIO Orchestra BioMed Holdings, Inc. Apr 12, 2023 2 $0 4 May 5, 2023 Chief Financial Officer
OBIO Orchestra BioMed Holdings, Inc. Jan 26, 2023 1 $0 4/A May 19, 2023 Chief Financial Officer
OBIO Orchestra BioMed Holdings, Inc. Jan 26, 2023 1 $0 4/A May 5, 2023 Chief Financial Officer
OBIO Orchestra BioMed Holdings, Inc. Jan 26, 2023 0 $0 3 Jan 30, 2023 Chief Financial Officer